Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by stocktradinguruon Sep 22, 2020 6:07am
306 Views
Post# 31596108

Write- down of $1.8 billion and earnings of

Write- down of $1.8 billion and earnings of

$70 to $72 million----Already priced into share price???

Some talking head on Motley Fool said just that.

hmmmm. I am honestly not sure. My experience with share price ---when a company announces a huge write-down on earnings day---is the stock Gaps down,,,


Lets see if the bearish news is already priced into ACB's share price.

Lets also look at bids and asks pre-market, which will likely determine a pissible opening share price.


Based on my stock trading experience, I expect a "Gap down".

The question is, "when to buy in?"

A word of caution: If ACB gaps down, we should know the stock price range in the first hour.

Another scenario that's  quite common is an oversold bounce---when the relative strenghth index drops below 30, after a huge sell off, theb traders buy the stock, run it up......sell it off, and the stock falls ...

I don't believe the bad news is already priced into ACB's share price....

That's why I am all cash "looking for a bottom fishing" buy in...

We could see some FOMO if ACB announces something positive....

I am just speculating.

If ACB drops to $7.39----a major support, I'll buy. Orherwise, I will wait a few days or weeks ans buy ACB stock when it begins accumulating----trading in a range, look to buy at the support....what ever that share price will be.

A word of advice: Never listen to a talking head, columnist, analyst----they are more often wrong than right. When it comes to stock picking, You can never predict the future share price. If you could, we'd all be rich.

So, I wait patiently....expecting a Gap down....But WTF do I know----that's why I am all cash.



 

<< Previous
Bullboard Posts
Next >>